Regulatory Affairs Services

Embrace limitless growth possibilities with Freyr's Regulatory Affairs services. Navigate Regulatory landscapes effortlessly and amplify your product's value to dominate in the life sciences, pharma, and consumer realms. Let's elevate your product’s market impact.

  • ZERO
    Refusal-to-File from Any Agency, due to CMC Technical Errors
  • 260

    +

    Regulatory Affairs Experts
  • 18000

    +

    Projects
  • 100

    +

    Countries
  • 8
    Forbes Global Top 10 Drug and Biotech Companies
  • 65

    +

    Mid and Small Bio-Tech / Bio-Similar Companies
  • 190

    +

    Generics and API Manufacturers/Sponsors
  • 400

    +

    Products
  • 250

    +

    Formulations

Regulatory Affairs Services - Overview

Regulatory Affairs Services play a vital role in ensuring the successful development and commercialization of drugs as they navigate the complex and ever-changing landscape of Global Health Authorities (HA). Ensuring compliance throughout the process is a mandatory requirement. To avoid overlooking procedures across the product life cycle, organizations deploy proven experts for Regulatory Affairs Services and consulting. The expert team acts as a crucial link between the organization and global HAs, tracking all the key regulations related to the product and prerequisites for its launch. In the current situation, not many organizations have the privilege of having these teams in-house, given their dedicated focus and approach toward innovation and drug safety.

As a specialized global Regulatory service consulting partner, Freyr acts as a bridge between organizations and key Regulatory authorities like the US FDA, Health Canada, and the European Medicines Agency. Freyr is a leading Regulatory Affairs Services company and has been a pioneer in providing strategic Regulatory support services globally. Freyr provides comprehensive Regulatory Affairs Services across the spectrum of product development, registration, and commercialization.

Freyr’s global Regulatory Affairs Services consultants enable life sciences, consumer, pharma, and biological products and medical devices companies to understand and efficiently manage the demanding complexity of the diverse Regulatory requirements to successfully launch their products in new markets and maximize their market value.

Regulatory Affairs Services

  • Regulatory submission forecast and planning
  • Submission document management and tracking
  • Regulatory content management
  • Change control management
  • Tracking label changes
  • Integrating Regulatory information
  • Regulatory Intelligence
  • Seasoned Regulatory experts upholding Regulatory compliance
  • Enhanced documentation support via in-house developed tools
  • Data-driven insights with AI-integrated tools
  • Accurate labeling implementation using industry benchmarking software
  • Informed Regulatory decision capabilities in line with global regulations
Regulatory-Affairs-Services-advantages

Success Stories

Freyr Supported Innovative Drug Research and Development Company with Type B Pre-IND Meeting Request and Meeting Package Submission
Regulatory Affairs

Freyr Supported Innovative Drug Research and Development Company with Type B Pre-IND Meeting Request and Meeting Package Submission

Freyr Supported the Compilation, Evaluation, and Submission of the Annual Report for a US-Based Pharmaceutical Company
Regulatory Affairs

Freyr Supported the Compilation, Evaluation, and Submission of the Annual Report for a US-Based Pharmaceutical Company

To ensure timely and accurate compliance with regulatory requirements by compiling, evaluating, and submitting the annual report to the USFDA, adhering to all relevant guidelines

Freyr Brought an Innovator Product to the EU and USA for an Italy-based Multinational Pharma Company with Comprehensive Regulatory Strategy and Support
Regulatory Affairs

Freyr Brought an Innovator Product to the EU and USA for an Italy-based Multinational Pharma Company with Comprehensive Regulatory Strategy and Support

The client, an Italy-based pharmaceutical company needed help expanding their innovator product into the EU and USA markets but lacked in-house Regulatory expertise. They turned to Freyr, who provided strategic guidance and end-to-end services, including submission support. Freyr's comprehensive assistance led to successful Regulatory proceedings, timely approvals, and enhanced compliance for their product in both markets.

Freyr Facilitated Product Development Meetings with the USFDA for a Pharma Giant Facing Issues with a Complex Generic Injectable Product
Regulatory Affairs

Freyr Facilitated Product Development Meetings with the USFDA for a Pharma Giant Facing Issues with a Complex Generic Injectable Product

An Italy-based pharmaceutical company had faced Regulatory challenges with the FDA for its complex generic injectable product and required comprehensive support to meet FDA requirements. They had turned to Freyr, who offered end-to-end assistance, including submission guidance and CFR-based recommendations. Freyr's support transformed the company's Regulatory strategy, ensured compliance, and streamlined the approval process.

Freyr Managed 15+ New and Approved Products (ANDAs/NDAs) for a Leading US Pharmaceutical Company with Comprehensive Regulatory Operations Support
Regulatory Affairs

Freyr Managed 15+ New and Approved Products (ANDAs/NDAs) for a Leading US Pharmaceutical Company with Comprehensive Regulatory Operations Support

A leading US pharmaceutical company had faced significant challenges in managing over 15 new and approved products (ANDAs/NDAs) due to a lack of in-house Regulatory expertise and limited FDA knowledge. Seeking comprehensive Regulatory support, they had turned to Freyr. Freyr's expert team provided strategic guidance, submission support, and ongoing Regulatory operations management, offering end-to-end Regulatory solutions that ensured seamless submission processes and continuous Regulatory compliance. As a result of Freyr's support, the pharmaceutical company achieved zero rejections and maintained Regulatory excellence.

Freyr Achieved Regulatory Success for Enzyme Replacement Therapy by Preparing BLAs for a Major Italian Pharma Company
Regulatory Affairs

Freyr Achieved Regulatory Success for Enzyme Replacement Therapy by Preparing BLAs for a Major Italian Pharma Company

The client, a major Italian pharmaceutical company, had faced stringent US FDA expectations for their enzyme replacement therapy products and struggled due to a lack of in-house BLA expertise and complex Regulatory challenges. Seeking comprehensive support, they had turned to Freyr. Freyr had provided strategic Regulatory submissions and expert guidance, ensuring seamless approvals. This empowered the client to manage future Regulatory issues independently, achieving Regulatory success and self-sufficiency.

Freyr Facilitated Seamless Management of Over 70 ANDAs/NDAs for a US-based Pharmaceutical Company Through Comprehensive End-to-End Regulatory Support
Regulatory Affairs

Freyr Facilitated Seamless Management of Over 70 ANDAs/NDAs for a US-based Pharmaceutical Company Through Comprehensive End-to-End Regulatory Support

A US-based pharmaceutical company had faced high attrition rates and limited in-house expertise, struggling with the Regulatory operations of 70+ ANDAs/NDAs. They had turned to Freyr for comprehensive Regulatory services. Freyr had provided strategic guidance and submission management, transforming the company's Regulatory operations. This support ensured seamless operations, timely approvals, and enhanced compliance.

Celebrating Customers Success

 

Medicinal Products

Regulatory Affairs

India

Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified. This continuously demonstrates Freyr's commitment towards our company’s milestones.

Director - Global Regulatory Affairs – Operations

India-based, Global Top Generic Pharma Company

 

Medicinal Products

Publishing

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Sr. Director, Head of Regulatory Operations

Ireland-based, Global Specialty Pharmaceutical Company

 

Medicinal Products

Regulatory Affairs

USA

Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions: that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.

Thank you for always being available and responding quickly and comprehensively to all my requests.

What a great team you have, Freyr.

Lynne McGrath

Regulatory Consultant

 

Medicinal Products

Regulatory Affairs

USA

Congratulations!!! ​

Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.

Assistant Manager​

US-based, Leading, Complex Generic Pharmaceutical Products Company​

 

Medicinal Products

Regulatory Affairs

USA

Thank you all for the great support!​

CEO

US-based, Leading Innovative Pharmaceuticals Company​

 

Medicinal Products

Regulatory Affairs

USA

The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company. ​

Thank you again, and we look forward to working with your team on the next project!

Senior Director of Business and Product Development​

US-based, Leading Innovator Pharmaceuticals Company​